|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 655 15th Street, NW |
Address2 | Suite 500 |
City | Washington |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 1262-12
|
||||||||
|
6. House ID# 305260000
|
TYPE OF REPORT | 8. Year | 2022 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Annetha Hall |
Date | 10/19/2022 3:36:16 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
S.56/H.R. 1474 Alzheimer's Caregiver Support Act
Americans Giving Care to Elders (AGE) Act of 2021 (H.R. 3689/S. 234)
S.104 Improving Social Determinants of Health Act of 2021
National Coronavirus Commission Act of 2021 (H.R. 1306/S. 412)
Advancing Connectivity during the Coronavirus to Ensure Support for Seniors (ACCESS) Act (H.R. 596/ S. 57)
NIH supplemental funding
S.333 COVID-19 Nursing Home Protection Act of 2021
S.962 American Cures Act
S.674 Public Health Infrastructure Saves Lives Act
FDA Neuroscience Center of Excellence
BRAIN Intiative funding
PACE Plus Act (S. 1162)
Nursing Home Reform Modernization Act (H.R. 1985/ S. 782)
Homecare for Seniors Act (H.R. 2898/S. 1399)
COVID HCBS Relief Act of 2021 (H.R. 525/S. 151)
Long-term care provisions within H.R.1319 the American Rescue Plan Act of 2021
Credit for Caring Act (H.R. 3321/S. 1670)
Comprehensive Care for Alzheimer's Act (H.R. 2517/S. 1125)
Equity in Neuroscience & Alzheimer's Clinical Trials (ENACT) Act of 2021 (H.R. 3085/S. 1548)
Elder Abuse Protection Act of 2021 (H.R. 2922)
Reducing COVID-19 Disparities by Investing in Public Health Act (H.R. 3904)
PROTECTS Act (S. 2214)
Provider Training in Palliative Care Act (S. 2890)
Choose Home Care Act of 2021 (S. 2562/H.R 5514)
Direct Care Opportunity Act (H.R. 2999)
Inflation Reduction Act of 2022 (H.R.5376)
Cures 2.0 Act (H.R. 6000)
Innovation in Aging Act (S. 3473)
Revitalizing the Aging Network Act (S. 3431)
Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act (S. 2706/H.R. 5030)
Stop the Wait Act of 2022 (S. 3575/H.R. 6583)
Palliative Care and Hospice Education and Training Act (S.4260)
NAPA Reauthorization Act (H.R. 7775/S 4203)
Alzheimer's Accountability and Investment Act (H.R. 7773/S 4202)
IMPROVE Nursing Homes Act (H.R. 8677)
Kevin and Avonte's Reauthorization Act of 2022 (H.R. 8907/S. 4885)
Mandating Exclusive Review of Individual Treatments (MERIT) Act (H.R. 9127)
Other matters related to COVID -19 and long COVID
Other matters related to elder justice
Other matters related to dementia care management models
Other matters related to younger-onset Alzheimer's disease
Other matters related to Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimers Disease
Other matters related to home- and community-based services
Other matters related to diversity in clinical trials
Other matters related to caregiving
Other matters related to biomedical research, Alzheimer's diagnostics, and patient-focused drug development
Other matters related to Social Security
Other matters related to related to user fee agreements and accelerated approval
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Veterans Affairs - Dept of (VA), Centers For Disease Control & Prevention (CDC), Administration on Aging, Natl Institutes of Health (NIH), Social Security Administration (SSA), Justice - Dept of (DOJ), Food & Drug Administration (FDA), Commerce - Dept of (DOC), Federal Emergency Management Agency (FEMA), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Conant |
|
|
|
Sarah |
Tellock |
|
|
|
Jennifer |
Pollack |
|
|
|
Laura |
Thornhill |
|
|
|
Courtney |
Veatch |
|
|
|
Sean |
Smith |
|
|
|
Amy |
Heath |
|
|
|
Brianna |
Battle |
|
|
|
Evan |
Holler |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R.4502 - Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022 (Labor, Health and Human Services, Education and Related Agencies FY22 Appropriations for Alzheimer's activities at: NIH, CDC, HRSA, ACL, Office of the HHS Secretary)
H.R.4372 - Department of the Interior, Environment, and Related Agencies Appropriations Act, 2022 (Interior, Environment and Related Agencies FY22 Appropriations for Alzheimer's activities at IHS)
H.R. 4350, National Defense Authorization Act for FY 2022 (Defense FY22 Appropriations for Alzheimer's activities at DHA)
Labor, Health and Human Services, Education and Related Agencies FY23 Appropriations for Alzheimer's activities at: NIH, CDC, HRSA, ACL, Office (H.R. 8295/S. 4659)
of the HHS Secretary
Interior, Environment and Related Agencies FY23 Appropriations for Alzheimer's activities at IHS (H.R. 8262/S. 4686)
Defense FY23 Appropriations for Alzheimer's activities at DHA (H.R. 8236/S. 4663)
17. House(s) of Congress and Federal agencies Check if None
Indian Health Service
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Conant |
|
|
|
Sarah |
Tellock |
|
|
|
Courtney |
Veatch |
|
|
|
Laura |
Thornhill |
|
|
|
Jennifer |
Pollack |
|
|
|
Brianna |
Battle |
|
|
|
Evan |
Holler |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
S.243 Legacy IRA Act, to incentivize more seniors to give to charities
S.618/H.R.1704 Universal Giving Pandemic Response and Recovery Act, to further incentivize all taxpayers to give to charity-regardless of their income or whether they itemize-helping to spur more even more giving as communities fight and recover from COVID-19 and its economic effects
SECURE 2.0 (S. 306/H.R. 2954)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Conant |
|
|
|
Courtney |
Veatch |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |